Modulight Oyj (MODU.HE)
EUR 1.37
(0.59%)
EUR 1.37
(0.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.23 Million EUR | -23.31% |
| 2022 | 10.73 Million EUR | -5.49% |
| 2021 | 11.36 Million EUR | 12.47% |
| 2020 | 10.1 Million EUR | 31.04% |
| 2019 | 7.7 Million EUR | 34.96% |
| 2018 | 5.71 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 7.44 Million EUR | -14.05% |
| 2024 Q1 | 8.08 Million EUR | -1.87% |
| 2024 Q2 | 8.66 Million EUR | 7.21% |
| 2023 Q3 | 8.23 Million EUR | -12.88% |
| 2023 FY | 8.23 Million EUR | -23.31% |
| 2023 Q4 | 8.23 Million EUR | 0.0% |
| 2023 Q2 | 9.45 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q2 | 11.53 Million EUR | 0.0% |
| 2022 FY | 10.73 Million EUR | -5.49% |
| 2022 Q4 | 10.73 Million EUR | 0.0% |
| 2022 Q3 | 10.73 Million EUR | -6.93% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q4 | 11.36 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 FY | 11.36 Million EUR | 12.47% |
| 2021 Q2 | 13.45 Million EUR | 0.0% |
| 2021 Q3 | 11.36 Million EUR | -15.54% |
| 2020 FY | 10.1 Million EUR | 31.04% |
| 2020 Q4 | 10.1 Million EUR | 0.0% |
| 2019 FY | 7.7 Million EUR | 34.96% |
| 2018 FY | 5.71 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | 5.5 Million EUR | -49.591% |
| Nexstim Plc | 7.04 Million EUR | -16.862% |
| Revenio Group Oyj | 37.6 Million EUR | 78.098% |